As of Nov 17
| 0.00 / 0.00%|
The 4 analysts offering 12-month price forecasts for Corcept Therapeutics Inc have a median target of 23.50, with a high estimate of 30.00 and a low estimate of 6.00. The median estimate represents a +27.79% increase from the last price of 18.39.
The current consensus among 4 polled investment analysts is to Buy stock in Corcept Therapeutics Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.